Literature DB >> 2865725

Mortality findings for stepped-care and referred-care participants in the hypertension detection and follow-up program, stratified by other risk factors. The Hypertension Detection and Follow-up Program Cooperative Research Group.

.   

Abstract

Analyses of 5-year mortality data from the Hypertension Detection and Follow-up Program (HDFP) were performed with stratification according to several baseline traits. The HDFP participants were 10,940 white and black men and women ages 30-69 at baseline who were randomized to either stepped-care (SC) or referred-care (RC) groups. All-causes mortality rates were lower for the SC than the RC group, both overall and for the 90-104 mm Hg stratum, for both cigarette smokers and nonsmokers, and for persons with and without hypercholesterolemia, hyperglycemia, diagnosed diabetes, hyperuricemia, or rapid pulse rate. The SC group also fared better than RC for all strata of body mass index, with an apparent trend toward an inverse relationship between body mass index and degree of benefit. Several of the traits--cigarette smoking, fasting hyperglycemia, and hyperuricemia--were associated with significantly higher 5-year mortality rates in both SC and RC participants, in both univariate and multivariate analyses, and a significant U-shaped relationship was recorded between body mass index and mortality for both SC and RC groups. These findings indicate the broad benefit of vigorous antihypertensive stepped-care treatment for hypertensive patients regardless of the presence or absence of the other major risk factors. They also underscore the need for comprehensive management of persons with high blood pressure to control not only their hypertension but also other risk factors associated with negative impact on long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865725     DOI: 10.1016/0091-7435(85)90059-3

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  11 in total

Review 1.  Hyperuricemia and renal function.

Authors:  L M Ruilope; J Garcia-Puig
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

2.  Racial and Ethnic Disparities in Diagnosis of Chronic Medical Conditions in the USA.

Authors:  Eun Ji Kim; Taekyu Kim; Joseph Conigliaro; Jane M Liebschutz; Michael K Paasche-Orlow; Amresh D Hanchate
Journal:  J Gen Intern Med       Date:  2018-05-07       Impact factor: 5.128

Review 3.  Experiences from hypertension trials. Impact of other risk factors.

Authors:  O Samuelsson
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

5.  Disparities in Hypertension Associated with Limited English Proficiency.

Authors:  Eun Ji Kim; Taekyu Kim; Michael K Paasche-Orlow; Adam J Rose; Amresh D Hanchate
Journal:  J Gen Intern Med       Date:  2017-02-03       Impact factor: 5.128

6.  Cardiovascular disease prevention practices by U.S. Physicians for patients with diabetes.

Authors:  J B Meigs; R S Stafford
Journal:  J Gen Intern Med       Date:  2000-04       Impact factor: 5.128

7.  Evidence-based approach for managing hypertension in type 2 diabetes.

Authors:  Gerti Tashko; Robert A Gabbay
Journal:  Integr Blood Press Control       Date:  2010-05-24

8.  Blood pressure targets for hypertension in patients with type 2 diabetes.

Authors:  Wilbert S Aronow; Tatyana A Shamliyan
Journal:  Ann Transl Med       Date:  2018-06

Review 9.  Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis.

Authors:  Tianqiang Qin; Xiaoqin Zhou; Ji Wang; Xinyu Wu; Yulin Li; Ling Wang; He Huang; Jing Li
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-06-01       Impact factor: 3.738

10.  The influence of diabetes on short-term outcome following a prosthetic above-the-knee femoro-popliteal bypass.

Authors:  T V Mulaudzi; J V Robbs; N Paruk; B Pillay; T E Madiba; V Govindsamy
Journal:  Cardiovasc J Afr       Date:  2009 May-Jun       Impact factor: 1.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.